Considerations for continuing diet therapy in patients with epilepsy during the COVID-19 pandemic: A scoping review

Diet therapy is an option for managing patients with drug-resistant epilepsy (DRE). Diet therapies used for patients with epilepsy include the classic ketogenic diet, the modified Atkins diet, the medium chain triglyceride diet, and the low glycemic index diet. The effectiveness of diet therapy is h...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Naoto Kuroda, Ayataka Fujimoto
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Coronavirus disease (COVID-19) Diet therapy Epilepsy Ketogenic diet Telemedicine Neurology. Diseases of the nervous system RC346-429 Neurophysiology and neuropsychology QP351-495
Acceso en línea:	https://doaj.org/article/e3e8b83cb5a5442b8db229e7429c9f18
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e3e8b83cb5a5442b8db229e7429c9f18
record_format	dspace
spelling	oai:doaj.org-article:e3e8b83cb5a5442b8db229e7429c9f182021-11-22T04:29:15ZConsiderations for continuing diet therapy in patients with epilepsy during the COVID-19 pandemic: A scoping review2589-986410.1016/j.ebr.2021.100498https://doaj.org/article/e3e8b83cb5a5442b8db229e7429c9f182021-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2589986421000721https://doaj.org/toc/2589-9864Diet therapy is an option for managing patients with drug-resistant epilepsy (DRE). Diet therapies used for patients with epilepsy include the classic ketogenic diet, the modified Atkins diet, the medium chain triglyceride diet, and the low glycemic index diet. The effectiveness of diet therapy is highly dependent on dietary adherence. Coronavirus disease (COVID-19), a novel infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has substantially impacted the lifestyles of people worldwide. Therefore, continuing a specific diet during the COVID-19 pandemic is expected to be difficult in some aspects. Here, based on the available literature, we summarize the perspectives for maintaining diet therapy during the COVID-19 pandemic, as a scoping review. Epileptologists and dieticians need to understand the difficulty of maintaining diet therapy during the COVID-19 pandemic. In addition, the education of patients and all stakeholders to continue diet therapy even during the current COVID-19 pandemic is crucial to control epileptic seizures. In conclusion, continuing diet therapy is not a matter only for patients during the COVID-19 pandemic, but medical staff should also help patients to overcome the problems associated with the pandemic by understanding their situations.Naoto KurodaAyataka FujimotoElsevierarticleCoronavirus disease (COVID-19)Diet therapyEpilepsyKetogenic dietTelemedicineNeurology. Diseases of the nervous systemRC346-429Neurophysiology and neuropsychologyQP351-495ENEpilepsy & Behavior Reports, Vol 16, Iss , Pp 100498- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Coronavirus disease (COVID-19) Diet therapy Epilepsy Ketogenic diet Telemedicine Neurology. Diseases of the nervous system RC346-429 Neurophysiology and neuropsychology QP351-495
spellingShingle	Coronavirus disease (COVID-19) Diet therapy Epilepsy Ketogenic diet Telemedicine Neurology. Diseases of the nervous system RC346-429 Neurophysiology and neuropsychology QP351-495 Naoto Kuroda Ayataka Fujimoto Considerations for continuing diet therapy in patients with epilepsy during the COVID-19 pandemic: A scoping review
description	Diet therapy is an option for managing patients with drug-resistant epilepsy (DRE). Diet therapies used for patients with epilepsy include the classic ketogenic diet, the modified Atkins diet, the medium chain triglyceride diet, and the low glycemic index diet. The effectiveness of diet therapy is highly dependent on dietary adherence. Coronavirus disease (COVID-19), a novel infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has substantially impacted the lifestyles of people worldwide. Therefore, continuing a specific diet during the COVID-19 pandemic is expected to be difficult in some aspects. Here, based on the available literature, we summarize the perspectives for maintaining diet therapy during the COVID-19 pandemic, as a scoping review. Epileptologists and dieticians need to understand the difficulty of maintaining diet therapy during the COVID-19 pandemic. In addition, the education of patients and all stakeholders to continue diet therapy even during the current COVID-19 pandemic is crucial to control epileptic seizures. In conclusion, continuing diet therapy is not a matter only for patients during the COVID-19 pandemic, but medical staff should also help patients to overcome the problems associated with the pandemic by understanding their situations.
format	article
author	Naoto Kuroda Ayataka Fujimoto
author_facet	Naoto Kuroda Ayataka Fujimoto
author_sort	Naoto Kuroda
title	Considerations for continuing diet therapy in patients with epilepsy during the COVID-19 pandemic: A scoping review
title_short	Considerations for continuing diet therapy in patients with epilepsy during the COVID-19 pandemic: A scoping review
title_full	Considerations for continuing diet therapy in patients with epilepsy during the COVID-19 pandemic: A scoping review
title_fullStr	Considerations for continuing diet therapy in patients with epilepsy during the COVID-19 pandemic: A scoping review
title_full_unstemmed	Considerations for continuing diet therapy in patients with epilepsy during the COVID-19 pandemic: A scoping review
title_sort	considerations for continuing diet therapy in patients with epilepsy during the covid-19 pandemic: a scoping review
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/e3e8b83cb5a5442b8db229e7429c9f18
work_keys_str_mv	AT naotokuroda considerationsforcontinuingdiettherapyinpatientswithepilepsyduringthecovid19pandemicascopingreview AT ayatakafujimoto considerationsforcontinuingdiettherapyinpatientswithepilepsyduringthecovid19pandemicascopingreview
_version_	1718418194123718656

Considerations for continuing diet therapy in patients with epilepsy during the COVID-19 pandemic: A scoping review

Ejemplares similares